<PAGE>


================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                          ----------------------------

                                   FORM 10-Q/A
                                 Amendment No. 1

(Mark One)

[X]       QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
          SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended June 30, 2001

                                      -OR-

[ ]       TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
          EXCHANGE ACT OF 1934

                     For the transition period from...to...


                           Commission File No. 0-24936


                            ERGO SCIENCE CORPORATION
             (Exact name of registrant as specified in its charter)


                Delaware                                       04-3271667
     (State or other jurisdiction of                        (I.R.S. Employer
     incorporation or organization)                      Identification Number)

           790 Turnpike Street
      North Andover, Massachusetts                               01845
(Address of principal executive offices)                      (Zip Code)


       Registrant's telephone number, including area code: (978) 689-0333


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.  Yes [X]  No [ ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

At August 2, 2001 there were 14,299,217 shares of common stock, par value $.01
per share, of the registrant outstanding.

================================================================================


<PAGE>


                                 AMENDMENT NO. 1

     The undersigned registrant hereby amends its Quarterly Report on Form 10-Q,
for the quarterly period ended June 30, 2001 (the "Report"), by (a) deleting in
its entirety the redacted version of Exhibit 10.1 filed with the Report and
inserting in place thereof the unredacted version of Exhibit 10.1 filed with
this Amendment No. 1, and (b) deleting in its entirety Item 6(a) of Part II of
the Report and inserting in place thereof Item 6(a) of Part II as set forth
below:


                                     PART II

                                OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

(a)      Exhibits:

         Exhibit Number                Document Description

             10.1        Common Stock Purchase Agreement dated May 23, 2001, by
                         and among the Ergo Science Corporation, ESC Merger Sub,
                         Inc. and Court Square Capital Limited.



                                       2
<PAGE>


                                   SIGNATURES


     Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this Amendment to be signed
on its behalf by the undersigned, thereunto duly authorized.



                                 ERGO SCIENCE CORPORATION



                                 By: /s/ J. Richard Crowley
                                     -----------------------------------------
                                     J. Richard Crowley
                                     Controller (principal accounting officer)



                                 Date:  September 7, 2001
                                        --------------------------------------




                                       3